US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Pharmaceuticals Market Research Reports & Industry Analysis

The pharmaceutical industry is directly impacted by the research conducted with prescription drugs, vaccines, and OTC drugs being manufactured based on findings from the study of life sciences. Clinical trials are conducted to ensure that products being developed are tested on how well they work on individuals affected by the diseases or conditions they are created to treat.
The market research available can provide investors and analysts credible information on the direction of pharmaceuticals, anesthesia, drug delivery, pricing, regulations and policy being developed to ensure that knowledgeable and informed decisions are made regarding industry direction.
  • Biopharmaceuticals (276)
  • Diseases & Conditions (5819)
  • Drug Delivery (246)
  • Therapeutic Area (8255)
  • Vaccines (818)
RSS Feeds

Pharmaceuticals Industry Research & Market Reports

< prev 1    3  4  5  6  7  8  9  10  
Global Central Nervous System Partnering 2010-2016: Deal trends, players and financials
2/1/2016 | published by: Current Partnering
... Financial deal terms for headline, upfront and royalty by stage of development Central Nervous System partnering agreement structure Central Nervous System partnering contract documents Top Central Nervous System deals by value Most active Central Nervous ...  |  read more...
USD 3,495
Global Dental Partnering 2010-2016: Deal trends, players and financials
2/1/2016 | published by: Current Partnering
... and royalty by stage of development Dental partnering agreement structure Dental partnering contract documents Top Dental deals by value Most active Dental dealmakers Most of the deals included within the report occur when a licensee ...  |  read more...
USD 2,995
Global Dermatology Partnering 2010-2016: Deal trends, players and financials
2/1/2016 | published by: Current Partnering
... deals Financial deal terms for headline, upfront and royalty by stage of development Dermatology partnering agreement structure Dermatology partnering contract documents Top Dermatology deals by value Most active Dermatology dealmakers Most of the deals included ...  |  read more...
USD 2,995
Global Gastrointestinal Partnering 2010-2016: Deal trends, players and financials
2/1/2016 | published by: Current Partnering
... and royalty by stage of development Gastrointestinal partnering agreement structure Gastrointestinal partnering contract documents Top Gastrointestinal deals by value Most active Gastrointestinal dealmakers Most of the deals included within the report occur when a licensee ...  |  read more...
USD 2,995
Vitamins and Dietary Supplements in the United Arab Emirates
1/21/2016 | published by: Euromonitor International
... the easy availability of fast food and a living environment which encourages eating habits with a high level of carbohydrates and fat-laden food. As the country is a desert, most fruit and vegetables are often ...  |  read more...
USD 990
Global Genetic disorders Partnering 2010-2016: Deal trends, players and financials
2/1/2016 | published by: Current Partnering
... for headline, upfront and royalty by stage of development Genetic Disorders partnering agreement structure Genetic Disorders partnering contract documents Top Genetic Disorders deals by value Most active Genetic Disorders dealmakers Most of the deals included ...  |  read more...
USD 2,995
Global Infectious Diseases Partnering 2010-2016: Deal trends, players and financials
2/1/2016 | published by: Current Partnering
... for headline, upfront and royalty by stage of development Infectious Diseases partnering agreement structure Infectious Diseases partnering contract documents Top Infectious Diseases deals by value Most active Infectious Diseases dealmakers Most of the deals included ...  |  read more...
USD 3,495
Global Metabolic Partnering 2010-2016: Deal trends, players and financials
2/1/2016 | published by: Current Partnering
... and royalty by stage of development Metabolic partnering agreement structure Metabolic partnering contract documents Top Metabolic deals by value Most active Metabolic dealmakers Most of the deals included within the report occur when a licensee ...  |  read more...
USD 2,995
Global Musculoskeletal Partnering 2010-2016: Deal trends, players and financials
2/1/2016 | published by: Current Partnering
... and royalty by stage of development Musculoskeletal partnering agreement structure Musculoskeletal partnering contract documents Top Musculoskeletal deals by value Most active Musculoskeletal dealmakers Most of the deals included within the report occur when a licensee ...  |  read more...
USD 2,995
Global Obstetrics Partnering 2010-2016: Deal trends, players and financials
2/1/2016 | published by: Current Partnering
... and royalty by stage of development Obstetrics partnering agreement structure Obstetrics partnering contract documents Top Obstetrics deals by value Most active Obstetrics dealmakers Most of the deals included within the report occur when a licensee ...  |  read more...
USD 2,995
Global Orphan Diseases Partnering 2010-2016: Deal trends, players and financials
2/1/2016 | published by: Current Partnering
... for headline, upfront and royalty by stage of development Orphan Diseases partnering agreement structure Orphan Diseases partnering contract documents Top Orphan Diseases deals by value Most active Orphan Diseases dealmakers Most of the deals included ...  |  read more...
USD 2,995
Global Pediatrics Partnering 2010-2016: Deal trends, players and financials
2/1/2016 | published by: Current Partnering
... and royalty by stage of development Pediatrics partnering agreement structure Pediatrics partnering contract documents Top Pediatrics deals by value Most active Pediatrics dealmakers Most of the deals included within the report occur when a licensee ...  |  read more...
USD 2,995
Global Psychiatry Partnering 2010-2016: Deal trends, players and financials
2/1/2016 | published by: Current Partnering
... and royalty by stage of development Psychiatry partnering agreement structure Psychiatry partnering contract documents Top Psychiatry deals by value Most active Psychiatry dealmakers Most of the deals included within the report occur when a licensee ...  |  read more...
USD 2,995
Global Respiratory Partnering 2010-2016: Deal trends, players and financials
2/1/2016 | published by: Current Partnering
... and royalty by stage of development Respiratory partnering agreement structure Respiratory partnering contract documents Top Respiratory deals by value Most active Respiratory dealmakers Most of the deals included within the report occur when a licensee ...  |  read more...
USD 2,995
Alnylam Pharmaceuticals Partnering Deals and Alliances 2010 to 2016
2/1/2016 | published by: Current Partnering
... inclusion of the most up to date deal and company data. The report will be delivered in PDF format within 1 working day of receipt of order. If the CD-Rom version purchased, the report will ...  |  read more...
USD 1,495
Amylin Pharmaceuticals Partnering Deals and Alliances 2010 to 2016
2/1/2016 | published by: Current Partnering
... inclusion of the most up to date deal and company data. The report will be delivered in PDF format within 1 working day of receipt of order. If the CD-Rom version purchased, the report will ...  |  read more...
USD 1,495
BioCryst Pharmaceuticals Partnering Deals and Alliances 2010 to 2016
2/1/2016 | published by: Current Partnering
... inclusion of the most up to date deal and company data. The report will be delivered in PDF format within 1 working day of receipt of order. If the CD-Rom version purchased, the report will ...  |  read more...
USD 1,495
Enzon Pharmaceuticals Partnering Deals and Alliances 2010 to 2016
2/1/2016 | published by: Current Partnering
... inclusion of the most up to date deal and company data. The report will be delivered in PDF format within 1 working day of receipt of order. If the CD-Rom version purchased, the report will ...  |  read more...
USD 1,495
Isis Pharmaceuticals Partnering Deals and Alliances 2010 to 2016
2/1/2016 | published by: Current Partnering
... inclusion of the most up to date deal and company data. The report will be delivered in PDF format within 1 working day of receipt of order. If the CD-Rom version purchased, the report will ...  |  read more...
USD 1,495
NPS Pharmaceuticals Partnering Deals and Alliances 2010 to 2016
2/1/2016 | published by: Current Partnering
... inclusion of the most up to date deal and company data. The report will be delivered in PDF format within 1 working day of receipt of order. If the CD-Rom version purchased, the report will ...  |  read more...
USD 1,495
Global Vaccines Consumption 2016 Market Research Report
1/28/2016 | published by: QYResearch Group
... definitions, classifications, applications and industry chain structure. And development policies and plans are discussed as well as manufacturing processes and cost structures. Secondly, the report states the global Vaccines market size (volume and value), and ...  |  read more...
USD 4,000
Questcor Pharmaceuticals Partnering Deals and Alliances 2010 to 2016
2/1/2016 | published by: Current Partnering
... inclusion of the most up to date deal and company data. The report will be delivered in PDF format within 1 working day of receipt of order. If the CD-Rom version purchased, the report will ...  |  read more...
USD 1,495
Regeneron Pharmaceuticals Partnering Deals and Alliances 2010 to 2016
2/1/2016 | published by: Current Partnering
... inclusion of the most up to date deal and company data. The report will be delivered in PDF format within 1 working day of receipt of order. If the CD-Rom version purchased, the report will ...  |  read more...
USD 1,495
GlaxoSmithkline Consumer Healthcare Ltd. : Consumer Packaged Goods - Company Profile, SWOT & Financial Analysis
1/22/2016 | published by: Canadean Ltd
... overview, key facts, major products and services, SWOT analysis, business description, company history, financial analysis, mergers & acquisitions, recent developments, key employees, company locations and subsidiaries as well as competitive benchmarking data. Key Findings This ...  |  read more...
USD 125
Czech Republic Pharmaceuticals and Healthcare Report Q2 2016
2/3/2016 | published by: BMI Research
... outlook will be the driving factor behindgrowth, with plans to further increase access to healthcare; pharmaceutical sales are expected to increaseover the coming years. Headline Expenditure Projections Pharmaceuticals: CZK78.83bn (USD3.01bn) in 2015 to CZK81.10bn (USD3.27bn) ...  |  read more...
USD 1,295
< prev 1    3  4  5  6  7  8  9  10